Related Experiment Video
Updated: Jun 1, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease
Lijun Dou1,2, Zhenxing Xu3, Jielin Xu1,2
1Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
This study identifies Parkinson's disease (PD) risk genes and repurposable drugs using a systems genetics approach. Simvastatin showed a reduced incidence of PD outcomes, suggesting its potential therapeutic value.
Area of Science:
- Neurogenetics
- Systems Biology
- Pharmacogenomics
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder with limited treatment options.
- Current therapies manage PD symptoms but do not halt disease progression.
Purpose of the Study:
- To identify potential Parkinson's disease (PD) risk genes.
- To discover repurposable drugs for PD treatment using a systems genetics approach.
Main Methods:
- Leveraged non-coding genome-wide association studies (GWAS) and brain-specific quantitative trait loci (xQTLs) within a protein-protein interactome (PPI) network.
- Prioritized 175 PD likely risk genes (pdRGs) enriched in druggable targets.
- Integrated network proximity drug repurposing with patient electronic health record (EHR) data.
Main Results:
- Identified 175 PD likely risk genes (pdRGs), including SNCA, LRRK2, and CD44.
- Simvastatin was significantly associated with reduced PD incidence (HR=0.91 for falls, HR=0.88 for dementia) after covariate adjustment.
- The identified pdRGs were differentially expressed across human brain cell types.
Conclusions:
- A network-based systems genetics framework can identify PD risk genes and potential therapeutic targets.
- Simvastatin shows promise as a repurposed drug for reducing PD incidence.
- The approach may be applicable to other neurodegenerative diseases.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Neural Regulation
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
EPS and iPS Cells in Disease Research

